The role of PET imaging in the management of patients with central nervous system disorders

Radiologic Clinics of North America

Volumn 43, Issue 1, 2005, Pages 49-65

  Newberg, Andrew B ^a   Alavi, Abass ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLSPIPERONE C 11; FLUORODEOXYGLUCOSE F 18; FLUORODOPA F 18; METHIONINE C 11; NEUROTRANSMITTER; RACLOPRIDE C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EPILEPSY; HEAD INJURY; HUMAN; NEUROPHYSIOLOGY; PARKINSON DISEASE; PICK PRESENILE DEMENTIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SEIZURE; SCINTISCANNING;

ALZHEIMER DISEASE; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM DISEASES; CEREBROVASCULAR DISORDERS; CRANIOCEREBRAL TRAUMA; EPILEPSY; HUMANS; PARKINSON DISEASE; PICK DISEASE OF THE BRAIN; POSITRON-EMISSION TOMOGRAPHY;

EID: 13944279583     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcl.2004.09.004     Document Type: Review

References (153)

1. H.F. Kung Overview of radiopharmaceuticals for diagnosis of central nervous disorders Crit Rev Clin Lab Sci 28 1991 269 286
2. B. Maziere, and M. Maziere Positron emission tomography studies of brain receptors Fundam Clin Pharmacol 5 1991 61 91
3. Therapeutic and Technology Assessment Subcommittee of the American Academy of Neurology Assessment: positron emission tomography Neurology 41 1991 163 167
4. F. Shtern Positron emission tomography as a diagnostic tool: a reassessment based on literature review Invest Radiol 27 1992 165 168
5. The Workshop Panel Advances in clinical imaging using positron emission tomography. National Cancer Institute workshop statement Arch Intern Med 150 1990 735 739
6. G. McKhann, D. Drachman, and M. Folstein Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurol 34 1984 939 944
7. M.C. Tierney, R.H. Gisher, and A.J. Lewis The NINCDS-ADRDA Workgroup criteria for the clinical diagnosis of probable Alzheimer's disease: a clinical pathological study of 57 cases Neurology 38 1988 359 364
8. C.L. Joachim, J.H. Morris, and D.J. Selkow Clinical diagnosed Alzheimer's disease: autopsy results in 150 cases Ann Neurol 24 1988 50 56
9. A. Alavi, M. Reivich, and S. Ferris Regional cerebral glucose metabolism in aging and senile dementia as determined by 18F-deoxyglucose and positron emission tomography S. Hoyer The aging brain: physiological and pathophysiological aspects 1982 Springer-Verlag Berlin 87 195
10. D.G. Jamieson, J.B. Chawluck, and A. Alavi The effect of disease severity on local cerebral glucose metabolism in Alzheimer's disease [abstract] J Cereb Blood Flow Metab 7 1987 S410
11. A. Kumar, M.B. Schapiro, and C. Grady High-resolution PET studies in Alzheimer's disease Neuropsychopharmacology 4 1991 35 46
12. M.E. Faulstich, and D.C. Sullivan Positron emission tomography in neuropsychiatry Invest Radiol 26 1991 184 194
13. F.J. Bonte, J. Hom, and R. Tinter Single photon tomography in Alzheimer's disease and the dementias Semin Nucl Med 20 1990 342 352
14. A. Ichimiya, K. Herholz, and R. Mielke Difference of regional cerebral metabolic pattern between presenile and senile dementia of the Alzheimer type: a factor analytic study J Neurol Sci 123 1994 11 17
15. R. Frackowiak, C. Pozilli, and N. Legg Regional cerebral oxygen supply and utilization in dementia: a clinical and physiological study with oxygen-15 and positron emission tomography Brain 104 1981 753 788
16. N.L. Foster, U. Mann, and E. Mohr Focal cerebral glucose hypometabolism in definite Alzheimer's disease Ann Neurol 26 1989 132 133
17. J.C. Mazziotta, R.S.J. Frackowiak, and M.E. Phelps The use of positron emission tomography in the clinical assessment of dementia Semin Nucl Med 22 1992 232 246
18. A. Newberg, A. Cotter, and M. Udeshi Metabolic imaging severity rating scale (MISRS) for the assessment of patients with cognitive impairment Clin Nucl Med 28 2003 565 570
19. N.R. Cutler, J. Haxby, and R. Duara Clinical history, brain metabolism, and neurophysiological function in Alzheimer's disease Ann Neurol 18 1985 298 309
20. R.P. Friedland, W.J. Jagust, and R.H. Huesman Regional cerebral glucose transport and utilization in Alzheimer's disease Neurology 39 1989 1427 1434
21. G.E. Alexander, K. Chen, and P. Pietrini Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer's disease treatment studies Am J Psychiatry 159 2002 738 745
22. H. Shinotoh, H. Namba, and K. Fukushi Brain acetylcholinesterase activity in Alzheimer disease measured by positron emission tomography Alzheimer Dis Assoc Disord 14 Suppl 1 2000 S114 S118
23. L. Tune, P.J. Tiseo, and J. Ieni Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease: results of a 24-week, double-blind, placebo-controlled study Am J Geriatr Psychiatry 11 2003 169 177
24. D.E. Kuhl, S. Minoshima, and K.A. Frey Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex Ann Neurol 48 2000 391 395
25. V. Kaasinen, K. Nagren, and T. Jarvenpaa Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease J Clin Psychopharmacol 22 2002 615 620
26. E. Salmon, P. Maquet, and B. Sadzot Positron emission tomography in Alzheimer's and Pick's disease J Neurol 235 1988 S1
27. A.P. Lieberman, J.Q. Trojanowski, and V.M. Lee Cog, neuroimaging, and pathological studies in a patient with Pick's disease Ann Neurol 43 1998 259 265
28. A.F. Wechsler, M.A. Verity, and S. Rosenchein Pick's disease: a clinical computed tomographic, and histologic study with Golgi impregnation observations Arch Neurol 39 1982 287 290
29. C.B. Wilson Metabolic imaging of human brain tumors Semin Neurol 9 1989 388 393
30. G. DiChiro Positron emission tomography using (18F) fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool Invest Radiol 22 1986 360 371
31. G. DiChiro, R.L. DeLaPaz, and R.A. Brooks Glucose utilization of cerebral gliomas measured by 18F fluorodeoxy-glucose and positron emission tomography Neurology 32 1982 1323 1329
32. L.A. O'Tuama Methionine transport in brain tumors J Neuropsychiatry 1 Suppl 1 1989 S37 S44
33. J.B. Alavi, A. Alavi, and J. Chawluk Positron emission tomography in patients with glioma: a predictor of prognosis Cancer 62 1988 1074 1078
34. D. Delbeke, C. Meyerowitz, and R.L. Lapidus Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET Radiology 195 1995 47 52
35. B. Katschten, A. Stevenaert, and B. Sadzot Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodexyglucose and/or carbon-11-methionine J Nucl Med 39 1998 778 785
36. M.J. Fulham, J.W. Melisi, and J. Nishimiya Neuroimaging of juvenile pilocytic astrocytomas: an enigma Radiology 189 1993 221 225
37. U. Roelcke, and K.L. Leenders Positron emission tomography in patients with primary CNS lymphomas J Neurooncol 43 1999 231 236
38. U. Lassen, P. Andersen, and G. Daugaard Metabolic and hemodynamic evaluation of brain metastases from small cell lung cancer with positron emission tomography Clin Cancer Res 4 1998 2591 2597
39. O. De Witte, M. Levivier, and P. Violon Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma Neurosurgery 39 1996 470 476
40. J.M. Rozental, R.L. Levine, and R.J. Nickles Changes in glucose uptake by malignant gliomas: preliminary study of prognostic significance J Neurooncol 10 1991 75 83
41. P.E. Ricci, J.P. Karis, and J.E. Heiserman Differentiating recurrent tumor from radiation necrosis: time for reevaluation of positron emission tomography? AJNR Am J Neuroradiol 19 1998 407 413
42. W.C. Olivero, S.C. Dulebohn, and J.R. Lister The use of PET in evaluating patients with primary brain tumors: Is it useful? J Neurol Neurosurg Psychiatry 58 1995 250 252
43. C.D. Marsden The mysterious motor function of the basal ganglia Neurology 32 1982 514 539
44. D. Eidelberg Positron emission tomography studies in parkinsonism Neurol Clin 10 1992 421 433
45. M. Guttman Dopamine receptors in Parkinson's disease Neurol Clin 10 1992 377 386
46. D. Rougemont, J.C. Baron, and P. Collard Local cerebral glucose utilization in treated and untreated patients with Parkinson's disease J Neurol Neurosurg Psychiatry 47 1984 824 830
47. D. Eidelberg, J.R. Moeller, and V. Dhawan The metabolic anatomy of Parkinson's disease: complementary (18F) fluorodeoxyglucose and (18F) fluorodopa positron emission tomographic studies Mov Disord 5 1990 203 213
48. W.R.W. Martin, A. Stoessel, and M.J. Adam Positron emission tomography in Parkinson's disease: glucose and dopa metabolism Adv Neurol 45 1987 95 98
49. S. Przedborski, S. Goldman, and N. Giladi Positron emission tomography in hemiparkinsonism-hemiatrophy syndrome Adv Neurol 60 1993 501 505
50. S. Dethy, N. Van Blercom, and P. Damhaut Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism Mov Disord 13 1998 275 280
51. R. Blesa, and J. Blin Levodopa-reduced glucose metabolism in striatopallidothalamocortico circuit in Parkinson's disease Neurology 41 1991 359
52. I.H. Jenkins, W. Fernandez, and E.D. Playford Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine Ann Neurol 32 1992 749 757
53. J.C. Mazziotta Movement disorders J.C. Maziotta S. Gilman Clinical brain imaging: principles and applications 1992 Davis Philadelphia 244 293
54. R.F. Peppard, W.R. Martin, and C.M. Clark Cortical glucose metabolism in Parkinson's and Alzheimer's disease J Neurosci Res 27 1990 561 568
55. D.E. Kuhl, E.J. Metter, and D.F. Benson Similarities of cerebral glucose metabolism in Alzheimier's and Parkinsonian dementia [abstract] J Nucl Med 26 1985 P69
56. J.O. Rinne, R. Portin, and H. Ruottinen Cog impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study Arch Neurol 57 2000 470 475
57. B.J. Weder, K.L. Leenders, and P. Vontobel Impaired somatosensory discrimination of shape in Parkinson's disease: association with caudate nucleus dopaminergic function Human Brain Map 8 1999 1 12
58. V.A. Holthoff-Detto, J. Kessler, and K. Herholz Functional effects of striatal dysfunction in Parkinson disease Arch Neurol 54 1997 145 150
59. D.J. Brooks, V. Ibanez, and G.V. Sawle Differing patterns of striatal (18F)-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy Ann Neurol 28 1990 547 555
60. C. Nahmias, E.S. Garnett, and G. Firnau Striatal dopamine distribution in Parkinsonian patients during life J Neurol Sci 69 1985 223 230
61. K.L. Leenders, E.P. Salmon, and P. Tyrrell The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease Arch Neurol 47 1990 1290 1298
62. O.G. Rousset, P. Deep, and H. Kuwabara Effect of partial volume correction on estimates of the influx and cerebral metabolism of 6-[(18)F]fluoro-L-dopa studied with PET in normal control and Parkinson's disease subjects Synapse 37 2000 81 89
63. E.S. Garnett, C. Nahmias, and G. Firnau Central dopaminergic pathways in hemiparkinsonism examined by positron emission tomography Can J Neurol Sci 11 1984 174 179
64. R. Torstenson, P. Hartvig, and B. Langstrom Differential effects of levodopa on dopaminergic function in early and advanced Parkinson's disease Ann Neurol 41 1997 334 340
65. D.J. Brooks PET studies and motor complications in Parkinson's disease Trends Neurosci 23 Suppl 10 2000 S101 S108
66. D.J. Brooks, P. Piccini, and N. Turjanski Neuroimaging of dyskinesia Ann Neurol 47 4 Suppl 1 2000 S154 S158
67. H. Shinotoh, K. Hirayama, and Y. Tateno Dopamine D1 and D2 receptors in Parkinson's disease and striatonigral degeneration determined by PET Adv Neurol 60 1993 488 493
68. G.V. Sawle, D.J. Brooks, and V. Ibanez Striatal D2 receptor density is inversely proportional to dopa uptake in untreated hemi-Parkinson's disease J Neurol Neurosurg Psychiatry 53 1990 177
69. A. Wijnand, F. Rutgers, and J.P.W. Lakke Tracing of dopamine receptors in hemiparkinsonism with positron emission tomography (PET) J Neurol Sci 80 1987 237 248
70. A. Antonini, J. Schwarz, and W.H. Oertel Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride Mov Disord 12 1997 33 38
71. J.M. Henselmans, B.M. de Jong, and J. Pruim Acute effects of thalamotomy and pallidotomy on regional cerebral metabolism, evaluated by PET Clin Neurol Neurosurg 102 2000 84 90
72. D. Eidelberg, J.R. Moeller, and T. Ishikawa Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease Ann Neurol 39 1996 450 459
73. P. Limousin, J. Greene, and P. Pollak Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease Ann Neurol 42 1997 283 291
74. K.D. Davis, E. Taub, and S. Houle Globus pallidus stimulation activates the cortical motor system during alleviation of parkinsonian symptoms Nat Med 3 1997 671 674
75. P. Piccini, O. Lindvall, and A. Bjorklund Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts Ann Neurol 48 2000 689 695
76. R.A. Hauser, T.B. Freeman, and B.J. Snow Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease Arch Neurol 56 1999 179 187
77. S.J. Read, T. Hirano, and D.F. Abbott The fate of hypoxic tissue on 18F-fluoromisonidazole positron emission tomography after ischemic stroke Ann Neurol 48 2000 228 235
78. G. Lenzi, R. Frackowiak, and T. Jonres Cerebral oxygen metabolism and blood flow in human cerebral ischemic infarction J Cereb Blood Flow Metab 2 1982 321 335
79. D.E. Kuhl, M. Phelps, and A. Kowell Effects of stroke on local cerebral metabolism and perfusion: mapping by emission tomography of 18FDG and 12NH3 Ann Neurol 8 1980 47 69
80. J. Baron, D. Rougemont, and M. Bousser Local interrelationships of cerebral oxygen consumption and glucose utilization in normal subjects and in ischemic stroke patients J Cereb Blood Flow Metab 4 1984 140 149
81. R. Wise, S. Bernardi, and R. Frackowiak Serial observations on the pathophysiology of acute stroke: the transition from ischemia to infarction as reflected in regional oxygen extraction Brain 106 1983 197 222
82. C.P. Derdeyn, A. Shaibani, and C.J. Moran Lack of correlation between pattern of collateralization and misery perfusion in patients with carotid occlusion Stroke 30 1999 1025 1032
83. S. Iglesias, G. Marchal, and F. Viader Delayed intrahemispheric remote hypometabolism: correlations with early recovery after stroke Cerebrovasc Dis 10 2000 391 402
84. N. Lassen The luxury perfusion syndrome and its possible relation to acute metabolic acidosis localized within the brain Lancet 2 1966 1113 1115
85. R. Wise, S. Bernardi, and R. Frackowiak Serial observations on the pathophysiology of acute stroke: the transition from ischemia to infarction as reflected in regional oxygen extraction Brain 106 1983 197 222
86. G. Marchal, A. Evans, and A. Dagher The evolution of cerebral infarction with time. A PET study of the ischemia penumbra J Cereb Blood Flow Metab 7 Suppl 1 1987 S99
87. J. Baron, M. Bousser, and A. Rey Reversal of focal "misery-perfusion syndrome'' by extra-intracranial arterial bypass in hemodynamic cerebral ischemia Stroke 12 1981 454 459
88. M. Kushner, A. Alavi, and M. Reivich Contralateral cerebellar hypometabolism following cerebral insult: a positron emission tomographics study Ann Neurol 15 1984 425 434
89. K. Herholz, W. Heindel, and A. Rackl Regional cerebral blood flow in leukoaraiosis and atherosclerotic carotid disease Arch Neurol 47 1990 392 397
90. J. Baron, M. Bousser, and D. Comar Crossed cerebellar diaschisis in human supratentorial brain infarction Trans Am Neurol Assoc 105 1980 459 461
91. J. Baron, M.G. Bousser, and D. Comar Crossed cerebellar diaschisis: a remote functional depression secondary to supratentorial infarction in man J Cereb Blood Flow Metab 1 1981 S500 S501
92. H. Yamauchi, H. Fukuyama, and Y. Nagahama Uncoupling of oxygen and glucose metabolism in persistent crossed cerebellar diaschisis Stroke 30 1999 1424 1428
93. J. De Reuck, D. Decoo, and I. Lemahieu Crossed cerebellar diaschisis after middle cerebral artery infarction Clin Neurol Neurosurg 99 1997 11 16
94. K. Broich, A. Alavi, and M. Kushner Positron emission tomography in cerebrovascular disorders Semin Nucl Med 22 1992 224 232
95. S. Iglesias, G. Marchal, and P. Rioux Do changes in oxygen metabolism in the unaffected cerebral hemisphere underlie early neurological recovery after stroke? A positron emission tomography study Stroke 27 1996 1192 1199
96. J. Gibbs, R. Wise, and K. Leenders Evaluation of cerebral perfusion reserve in patients with carotid-artery occlusion Lancet 1 1984 310 314
97. G. Sette, J. Baron, and B. Mazoyer Local brain hemodynamics and oxygen metabolism in cerebrovascular disease Brain 112 1989 931 951
98. W. Powers, G. Press, and R. Grubb The effect of hemodynamically significant carotid artery disease on the hemodynamic status of the cerebral circulation Ann Intern Med 106 1987 27 35
99. W. Powers, R. Grubb, and M. Raichle Clinical results of extracranial-intracranial bypass-surgery in patients with hemodynamic cerebrovascular disease J Neurosurg 70 1989 61 67
100. C.P. Derdeyn, T.O. Videen, and N.R. Simmons Count-based PET method for predicting ischemic stroke in patients with symptomatic carotid arterial occlusion Radiology 212 1999 499 506
101. C.P. Derdeyn, K.D. Yundt, and T.O. Videen Increased oxygen extraction fraction is associated with prior ischemic events in patients with carotid occlusion Stroke 29 1998 754 758
102. Y. Samson, J. Baron, and M. Bousser Effects of extra-intracranial arterial bypass on cerebral blood flow and oxygen metabolism in humans Stroke 16 1985 609 616
103. W. Powers, L. Tempel, and R. Grubb Influence of cerebral hemodynamics on stroke risk: one-year follow-up of 38 medically treated patients Ann Neurol 25 1989 325 330
104. W.D. Heiss, J. Kessler, and H. Karbe Cerebral glucose metabolism as a predictor of recovery from aphasia in ischemic stroke Arch Neurol 50 1993 958 964
105. H. Karbe, J. Kessler, and K. Herholz Long-term prognosis of poststroke aphasia studied with positron emission tomography Arch Neurol 52 1995 186 190
106. H.J. Rosen, S.E. Petersen, and M.R. Linenweber Neural correlates of recovery from aphasia after damage to left inferior frontal cortex Neurology 55 2000 1883 1894
107. M. Ohyama, M. Senda, and S. Kitamura Role of the nondominant hemisphere and undamaged area during word repetition in poststroke aphasics: a PET activation study Stroke 27 1996 897 903
108. H. Karbe, A. Thiel, and G. Weber-Luxenburger Brain plasticity in poststroke aphasia: what is the contribution of the right hemisphere? Brain Lang 64 1998 215 230
109. W.D. Heiss, J. Kessler, and A. Thiel Differential capacity of left and right hemispheric areas for compensation of poststroke aphasia Ann Neurol 45 1999 430 438
110. E. Warburton, C.J. Price, and K. Swinburn Mechanisms of recovery from aphasia: evidence from positron emission tomography studies J Neurol Neurosurg Psychiatry 66 1999 155 161
111. G. Nelles, G. Spiekramann, and M. Jueptner Evolution of functional reorganization in hemiplegic stroke: a serial positron emission tomographic activation study Ann Neurol 46 1999 901 909
112. W.D. Heiss, M. Grond, and A. Thiel Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke J Cereb Blood Flow Metab 18 1998 1298 1307
113. W.D. Heiss, M. Grond, and A. Thiel Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke Stroke 29 1998 454 461
114. W.D. Heiss, R. Graf, and M. Grond Quantitative neuroimaging for the evaluation of the effect of stroke treatment Cerebrovasc Dis 8 Suppl 2 1998 23 29
115. A. Hakim, A. Evans, and L. Berger The effect of nimodipine on the evolution of human cerebral infarction studies by PET J Cereb Blood Flow Metab 9 1989 523 534
116. W. Heiss, V. Holthoff, and G. Pawlik Effect of nimodipine on regional cerebral glucose metabolism in patients with acute ischemic stroke as measured by positron emission tomography J Cereb Blood Flow Metab 10 1990 127 132
117. T.W. Langfitt, W.D. Obrist, and A. Alavi Computerized tomography, magnetic resonance imaging, and positron emission tomography in the study of brain trauma. Preliminary observations J Neurosurg 64 1986 760 767
118. A. Alavi, T. Fazekas, and W. Alves Positron emission tomography in the evaluation of head injury [abstract] J Cereb Blood Flow Metab 7 1987 S646
119. J.K. George, A. Alavi, and R.A. Zimmerman Metabolic (PET) correlates of anatomic lesions (CT/MRI) produced by head trauma [abstract] J Nucl Med 30 1989 802
120. A. Alavi Functional and anatomic studies of head injury J Neuropsychiatry 1 1989 S45 S50
121. A. Alavi, A. Mirot, and A. Newberg F-18 PET evaluation of crossed cerebellar diaschisis in head injury J Nucl Med 38 1997 1717 1720
122. R.M. Ruff, J.A. Crouch, and A.I. Troster Selected cases of poor outcome following minor brain trauma: comparing neuropsychological and positron emission tomography assessment Brain Inj 8 1994 297 308
123. M. Bergsneider, D.A. Hovda, and S.M. Lee Dissociation of cerebral glucose metabolism and level of consciousness during the period of metabolic depression following human traumatic brain injury J Neurotrauma 17 2000 389 401
124. M. Bergsneider, D.A. Hovda, and E. Shalmon Cerebral hyperglycolysis following severe traumatic brain injury in humans: a positron emission tomography study J Neurosurg 86 1997 241 251
125. G. Worley, J.M. Hoffman, and S.S. Paine 18-Fluorodeoxyglucose positron emission tomography in children and adolescents with traumatic brain injury Dev Med Child Neurol 37 1995 213 220
126. B.M. de Jong, A.T. Willemsen, and A.M. Paans Regional cerebral blood flow changes related to affective speech presentation in persistent vegetative state Clin Neurol Neurosurg 99 1997 213 216
127. J. Engel Jr, D.E. Kuhl, and M.E. Phelps Comparative localization of the epileptic foci in partial epilepsy by PCT and EEG Ann Neurol 12 1982 529 537
128. W.H. Theodore, R. Brooks, and S. Sato The role of positron emission tomography in the evaluation of seizure disorders Ann Neurol 15 1984 S1176 S1179
129. T.R. Henry, W.W. Sutherling, and J. Engel Jr Interictal cerebral metabolism in partial epilepsies of neocortical origin Epilepsy Res 10 1991 174 182
130. R. Duncan Epilepsy, cerebral blood flow, and cerebral metabolic rate Cerebrovasc Brain Metab Rev 4 1992 105 121
131. H. Utsubo, S.H. Chuang, and P.A. Hwang Neuroimaging for investigation of seizures in children Pediatr Neurosurg 18 1992 105 116
132. J.I. Breier, N.A. Mullani, and A.B. Thomas Effects of duration of epilepsy on the uncoupling of metabolism and blood flow in complex partial seizures Neurology 48 1997 1047 1053
133. I. Savic, L. Altshuler, and L. Baxter Pattern of interictal hypometabolism in PET scans with fludeoxyglucose F 18 reflects prior seizure types in patients with mesial temporal lobe seizures Arch Neurol 54 1997 129 136
134. W.H. Theodore, W.D. Gaillard, and S. Sato Positron emission tomographic measurement of cerebral blood flow and temporal lobectomy Ann Neurol 36 1994 241 244
135. E.M. Manno, M.R. Sperling, and X. Ding Predictors of outcome after anterior temporal lobectomy: positron emission tomography Neurol 44 1994 2331 2336
136. R.A. Radtke, M.W. Hanson, and J.M. Hoffman Temporal lobe hypometabolism on PET: predictor of seizure control after temporal lobectomy Neurol 43 1993 1088 1092
137. C.-Y. Wong, E.B. Geller, and E.Q. Chen Outcome of temporal lobe epilepsy surgery predicted by statistical parametric PET imaging J Nucl Med 37 1996 1094 1100
138. W.H. Theodore, S. Sato, and C. Kufta Temporal lobectomy for uncontrolled seizures: the role of positron emission tomography Ann Neurol 32 1992 789 794
139. D. Delbeke, S.K. Lawrence, and B.W. Abou-Khalil Postsurgical outcome of patients with uncontrolled complex partial seizures and temporal lobe hypometabolism on 18FDG-positron emission tomography Invest Radiol 31 1996 261 266
140. S.R. Benbadis, N.K. So, and M.A. Antar The value of PET scan (and MRI and Wada test) in patients with bitemporal epileptiform abnormalities Arch Neurol 52 1995 1062 1068
141. B.E. Swartz, U. Tomiyasu, and A.V. Delgado-Escueta Neuroimaging in temporal lobe epilepsy: test sensitivity and relationships to pathology and postoperative outcome Epilepsia 33 1992 624 634
142. A. Newberg, A. Alavi, and M. Sperling Thalamic metabolic asymmetry on FDG-PET scans as a determinant of seizure outcome after temporal lobectomy J Nucl Med 38 1997 92P
143. O.N. Markand, V. Salanova, and R. Worth Comparative study of interictal PET and ictal SPECT in complex partial seizures Acta Neurol Scand 95 1997 129 136
144. V. Salanova, O. Markand, and R. Worth FDG-PET and MRI in temporal lobe epilepsy: relationship to febrile seizures, hippocampal sclerosis and outcome Acta Neurol Scand 97 1998 146 153
145. R.C. Knowlton, K.D. Laxer, and G. Ende Presurgical multimodality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy Ann Neurol 42 1997 829 837
146. E. Rubin, V. Dhawan, and J.R. Moeller Cerebral metabolic topography in unilateral temporal lobe epilepsy Neurol 45 1995 2212 2223
147. P. Van Bogaert, N. Massager, and P. Tugendhaft Statistical parametric mapping of regional glucose metabolism in mesial temporal lobe epilepsy Neuroimage 12 2000 129 138
148. L.F. Quesney, A. Olivier, and F. Andermann Preoperative EEG investigation in patients with frontal lobe epilepsy: trends, results and pathophysiological considerations J Clin Neurophysiol 4 1987 208 209
149. G. Franck, P. Maquet, and B. Sadzot Contribution of positron emission tomography to the investigation of epilepsies of frontal lobe origin Adv Neurol 57 1992 471 485
150. Y. Robitaille, T. Rasmussen, and F. Dubeau Histopathology of nonneoplastic lesions in frontal lobe epilepsy: review of 180 cases with recent MRI and PET correlations Adv Neurol 57 1992 499 511
151. A. Alavi, and L.J. Hirsch Studies of central nervous system disorders with single photon emission computed tomography and positron emission tomography: evolution over the past 2 decades Semin Nucl Med 21 1991 58 81
152. H.T. Chugani, P.J. Rintahaka, and D.A. Shewmon Ictal patterns of cerebral glucose utilization in children with epilepsy Epilepsia 35 1994 813 822
153. 2O and positron emission tomography Epilepsia 37 1996 796 802